XBiotech Inc.
XBIT
$2.27
-$0.04-1.73%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 354.71% | -3.30% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 392.06% | -4.56% | |||
| Operating Income | -392.06% | 4.56% | |||
| Income Before Tax | -354.05% | -241.78% | |||
| Income Tax Expenses | -25.49% | 264.29% | |||
| Earnings from Continuing Operations | -347.60% | -242.14% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -347.60% | -242.14% | |||
| EBIT | -392.06% | 4.56% | |||
| EBITDA | -422.72% | 4.70% | |||
| EPS Basic | -347.54% | -242.19% | |||
| Normalized Basic EPS | -363.42% | -242.09% | |||
| EPS Diluted | -347.54% | -242.19% | |||
| Normalized Diluted EPS | -363.42% | -242.09% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||